Table 3 Frequency of adverse events (only for incidence ≥ 10% in one or more vaccination groups)
Patients in population | Total (n = 37) |
|---|---|
n (%) | |
With one or more adverse events | 35 (94.6) |
With no adverse events | 2 (5.4) |
Injection site pain | 23 (62.2) |
Injection site erythema | 17 (45.9) |
Injection site swelling | 16 (43.2) |
Fatigue | 11 (29.7) |
Nausea | 7 (18.9) |
Diarrhoea | 5 (13.5) |
Dyspnoea | 5 (13.5) |
Nasopharyngitis | 5 (13.5) |
Arthralgia | 4 (10.8) |
Back pain | 4 (10.8) |
Cough | 4 (10.8) |
Dizziness | 4 (10.8) |
Pyrexia | 4 (10.8) |